Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Aalberts NV | AACA | Oct 7, 2024 | 35.02 | -1.24 |
Aallon Group | I74 | Oct 7, 2024 | 8.60 | +0.23 |
AAP Implantate AG | AAQ1 | Oct 7, 2024 | 1.77 | -4.84 |
AAR Corp. | ARZ | Oct 7, 2024 | 59.10 | +0.77 |
AB Akola Group | YG4 | Oct 7, 2024 | 1.11 | 0.00 |
AB Amber Grid | AMH | Oct 7, 2024 | 1.10 | +0.92 |
AB Dynamics plc | 6DY | Oct 7, 2024 | 21.60 | 0.00 |
AB Ignitis Grupe | IGV0 | Oct 7, 2024 | 18.36 | +0.77 |
AB S.A. | 8B6 | Oct 7, 2024 | 22.20 | -0.89 |
Ab Science | A8D | Oct 7, 2024 | 0.94 | +0.21 |
ABACUS GRP UTS | EZO1 | Oct 7, 2024 | 0.77 | -1.32 |
Abacus Mining & Exploration Corp. | DGV2 | Oct 7, 2024 | 0.01 | 0.00 |
ABB Ltd | ABJA | Oct 7, 2024 | 51.50 | 0.00 |
Abbott Laboratories | ABL | Oct 7, 2024 | 103.00 | +0.31 |
AbbVie Inc. | 4AB | Oct 7, 2024 | 177.40 | +0.12 |
ABC | EK7 | Oct 7, 2024 | 0.44 | -6.22 |
ABC Arbitrage | 9BA | Oct 7, 2024 | 4.50 | +2.51 |
ABC-Mart Inc. | 5B8 | Oct 7, 2024 | 18.10 | +1.12 |
AbCellera Biologics Inc. - | 8QQ | Oct 7, 2024 | 2.27 | -1.82 |
Abcourt Mines, Inc. | AML | Oct 7, 2024 | 0.04 | +46.94 |
ABEN MINERALS LTD | R26 | Oct 7, 2024 | 0.04 | +1.41 |
Abercrombie & Fitch Company | AFT | Oct 7, 2024 | 126.50 | -3.38 |
Aberdeen Asia-Pacific Income Fund Inc | 9J9 | Oct 7, 2024 | 2.40 | 0.00 |
Aberdeen Asia-Pacificome Fund | 9J90 | Oct 7, 2024 | 15.44 | 0.00 |
Aberdeen International Inc | A8H | Oct 7, 2024 | 0.02 | -3.13 |
Aberdeen Standard European Logistics Income Plc | 5JX | Oct 7, 2024 | 0.69 | -4.86 |
Aberforth Smaller Companies Trust PLC | 0KJ | Oct 7, 2024 | 18.20 | +1.11 |
ABG Sundal Collier Holding | DAB | Oct 7, 2024 | 0.56 | +1.09 |
Abionyx Pharma | 609 | Oct 7, 2024 | 1.16 | -0.17 |
Abitare In Spa | 1BN | Oct 7, 2024 | 4.17 | +2.71 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.